News & Press

Meet the Doctor: Dr. Vernon Sondak

August 31, 2020

Meet Dr. Vernon Sondak! This year the MRF is excited to have Dr. Sondak participate in our 2020 Virtual Pediatric Melanoma Summit from September 21-25, 2020 to help spread awareness about pediatric melanoma. Get to know more about him below!  Dr. Sonda …

What is Pediatric Melanoma?

August 31, 2020

Guest blog by Vernon Sondak, MD and Jane L. Messina, MD from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. Dr. Sondak will be presenting at our 2020 Virtual Pediatric Melanoma Summit.  Pediatric melanoma is defined as a mal …

FDA Approves Foundation Medicine’s FoundationOne Liquid CDx, a Comprehensive Pan-Tumor Liquid Biopsy Test

August 28, 2020

Washington, DC, August 28, 2020 – This week, the U.S. Food and Drug Administration (FDA) approved Foundation Medicine, Inc.’s comprehensive pan-tumor liquid biopsy test called FoundationOne Liquid CDx. This test analyzes more than 300 genes and genomic …

FDA Approves Atezolizumab to Treat BRAF V600 Unresectable or Metastatic Melanoma

July 31, 2020

Washington, DC, July 31, 2020 – On July 30, 2020, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.) in combination with cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresec …

House Appropriations Committee Includes $20 million for Defense-funded Melanoma Research

July 21, 2020

Washington, DC, July 21, 2020 – The Melanoma Research Foundation (MRF) commends the House Appropriations Committee for including $20 million for Department of Defense (DoD)-funded melanoma research in its Fiscal 2021 Department of Defense Appropriation …